NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 350 filers reported holding NOVAVAX INC in Q4 2020. The put-call ratio across all filers is 1.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $116 | +90.2% | 16,028 | +98.3% | 0.00% | – |
| Q2 2023 | $61 | +90.6% | 8,084 | +76.9% | 0.00% | – |
| Q1 2023 | $32 | -92.4% | 4,569 | -88.7% | 0.00% | -100.0% |
| Q4 2022 | $419 | -99.9% | 40,577 | +104.0% | 0.00% | 0.0% |
| Q3 2022 | $362,000 | -40.9% | 19,892 | +67.0% | 0.00% | -50.0% |
| Q2 2022 | $613,000 | -52.0% | 11,909 | -27.4% | 0.00% | -33.3% |
| Q1 2022 | $1,277,000 | -47.1% | 16,398 | -3.2% | 0.00% | -40.0% |
| Q4 2021 | $2,415,000 | -8.5% | 16,938 | +33.8% | 0.01% | -16.7% |
| Q3 2021 | $2,640,000 | -1.7% | 12,661 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $2,686,000 | +267.4% | 12,661 | +211.6% | 0.01% | +200.0% |
| Q1 2021 | $731,000 | +66.5% | 4,063 | +2.9% | 0.00% | +100.0% |
| Q4 2020 | $439,000 | +2.6% | 3,949 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $428,000 | +49.1% | 3,949 | +14.3% | 0.00% | 0.0% |
| Q2 2020 | $287,000 | +3487.5% | 3,454 | +120.4% | 0.00% | – |
| Q3 2019 | $8,000 | -52.9% | 1,567 | -47.0% | 0.00% | – |
| Q2 2019 | $17,000 | – | 2,954 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |